Concordance of Lumipulse cerebrospinal fluid t-tau/A β42 ratio with amyloid PET status.

DISCUSSION: Lumipulse CSF biomarker measures with validated cut-points have clinical utility in identifying AD pathology. PMID: 31914216 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/31914216?dopt=Abstract

Source: The Journal of Alzheimers Association - January 9, 2020 Category: Psychiatry Tags: Alzheimers Dement Source Type: research